Single-nuclei transcriptomics reveals TBX5-dependent targets in a patient with Holt-Oram syndrome.
IF 13.3
1区 医学
Q1 MEDICINE, RESEARCH & EXPERIMENTAL
引用次数: 0
单核转录组学揭示了一名霍尔特-奥拉姆综合征患者的 TBX5 依赖性靶点。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文
求助全文
来源期刊
Journal of Clinical Investigation
医学-医学：研究与实验
CiteScore
24.50
自引率
1.30%
发文量
1034
审稿时长
2 months
期刊介绍：
The Journal of Clinical Investigation, established in 1924 by the ASCI, is a prestigious publication that focuses on breakthroughs in basic and clinical biomedical science, with the goal of advancing the field of medicine. With an impressive Impact Factor of 15.9 in 2022, it is recognized as one of the leading journals in the "Medicine, Research & Experimental" category of the Web of Science.
The journal attracts a diverse readership from various medical disciplines and sectors. It publishes a wide range of research articles encompassing all biomedical specialties, including Autoimmunity, Gastroenterology, Immunology, Metabolism, Nephrology, Neuroscience, Oncology, Pulmonology, Vascular Biology, and many others.
The Editorial Board consists of esteemed academic editors who possess extensive expertise in their respective fields. They are actively involved in research, ensuring the journal's high standards of publication and scientific rigor.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
